Efficacy and Safety of Penpulimab Combined With Anlotinib and Chemotherapy

NCT06586242 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

194

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Cancer

Interventions

DRUG: Penpulimab;Anlotinib;albumin paclitaxel;oxaliplatin;lobaplatin

Sponsor

Xijing Hospital